Episode

Episode 506: ASCO 2026 - How do we measure quality of life in GU patients?

Podcast: The Uromigos
Published: May 30, 2026
Duration seconds: 1186
Processing state: not_requested
Canonical source: https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-506-ASCO-2026---How-do-we-measure-quality-of-life-in-GU-patients-e3k43nh
Audio: https://anchor.fm/s/13347ea8/podcast/play/120769713/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-30%2F425193900-44100-2-b81017b2fb4c3.m4a
JSON: /v1/public/podcasts/the-uromigos-1214845/episodes/episode-506-asco-2026-how-do-we-measure-quality-of-life-in-gu-patients
Markdown: /podcast/the-uromigos-1214845/episode-506-asco-2026-how-do-we-measure-quality-of-life-in-gu-patients.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-506-asco-2026-how-do-we-measure-quality-of-life-in-gu-patients/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-uromigos-1214845/episode-506-asco-2026-how-do-we-measure-quality-of-life-in-gu-patients.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

This panel discussion podcast with Brian, Tom, Peter O'Donnell and Elizabeth Nally explores the complexities of measuring quality of life in cancer clinical trials, highlighting recent data, patient perspectives, and innovative approaches to assessment. Experts discuss the limitations of current tools, the importance of long-term follow-up, and future directions for integrating patient-centered metrics.